How to buy INVO Bioscience stock (INVO Bioscience)

INVO Bioscience is a medical devices business based in the US. INVO Bioscience shares (INVO) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.75 – a decrease of 8.54% over the previous week. INVO Bioscience employs 25 staff and has a trailing 12-month revenue of around $5.8 million.

Our top picks for where to buy INVO Bioscience stock

Buy INVO Bioscience stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

INVO Bioscience stock price (NASDAQ: INVO)

Use our graph to track the performance of INVO stocks over time.

INVO Bioscience shares at a glance

• Key figures

Information last updated 2024-12-19.

Latest market close	$0.75
52-week range	$0.63 - $1.82
50-day moving average more info button	$0.77
200-day moving average more info button	$0.90
Wall St. target price	$20.00
PE ratio more info button	1.2072
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$0.69

Is it a good time to buy INVO Bioscience stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

INVO Bioscience price performance over time

Historical closes compared with the close of $0.76 from 2024-12-19

1 week (2024-12-13)	-7.32%
1 month (2024-11-21)	-13.14%
3 months (2024-09-20)	9.34%
6 months (2024-06-21)	-9.52%

1 year (2023-12-21)	-34.48%
2 years (2022-12-21)	-90.95%
3 years (2021-12-21)	78
5 years (2019-12-20)	140.48

Is INVO Bioscience stock undervalued or overvalued?

Valuing INVO Bioscience stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of INVO Bioscience's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

INVO Bioscience's P/E ratio

INVO Bioscience's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 1x. In other words, INVO Bioscience shares trade at around 1x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

However, INVO Bioscience's P/E ratio is best considered in relation to those of others within the medical devices industry or those of similar companies.

• Progyny (PGNY.US): 24.17
• The Cooper Companies IncCommon Stock (COO.US): 47.14
• OvaScience (OVAS.US): 0.00

INVO Bioscience financials

Revenue TTM	$5.8 million
Gross profit TTM	$535,273
Return on assets TTM	-26.57%
Return on equity TTM	-14358.64%
Profit margin	-122.8%
Book value	$-1.59
Market Capitalization more info button	$3.3 million

TTM: trailing 12 months

INVO Bioscience share dividends

We're not expecting INVO Bioscience to pay a dividend over the next 12 months.

You may also wish to consider:

Have INVO Bioscience's shares ever split?

INVO Bioscience's shares were split on a 1:20 basis on 27 July 2023 . So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your INVO Bioscience shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for INVO Bioscience shares which in turn could have impacted INVO Bioscience's share price.

INVO Bioscience share price volatility

Over the last 12 months, INVO Bioscience's shares have ranged in value from as little as $0.6311 up to $1.82. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while INVO Bioscience's is 1.436. This would suggest that INVO Bioscience's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

To put INVO Bioscience's beta into context you can compare it against those of similar companies.

• Progyny (PGNY.US): 1.44
• The Cooper Companies IncCommon Stock (COO.US): 0.99

INVO Bioscience overview

INVO Bioscience, Inc. , together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida. .

Frequently asked questions

What percentage of INVO Bioscience is owned by insiders or institutions?
Currently 0.63% of INVO Bioscience shares are held by insiders and 3.1% by institutions. How many people work for INVO Bioscience?
Latest data suggests 25 work at INVO Bioscience. When does the fiscal year end for INVO Bioscience?
INVO Bioscience's fiscal year ends in December. Where is INVO Bioscience based?
INVO Bioscience's address is: 5582 Broadcast Court, Sarasota, FL, United States, 34240 What is INVO Bioscience's ISIN number?
INVO Bioscience's international securities identification number is: US44984F3029